🧭 REBEL Rundown 📌 Key Points 💨 Most asthma patients still leave the ED with a SABA alone—time for an upgrade. 📉 SABA/ICS combo inhalers cut severe exacerbations compared to SABA alone. 🏥 Study excluded typical ED patients—few had recent ...
Bottom Line Up Top: In patients with mild to moderate asthma exacerbations that are stable for discharge home, there is evidence to support discharging patients from the ED with combination Inhaled Corticosteroid/Long-Acting Beta Agonist (ICS-LABA) maintenance therapy. Clinical Scenario: A ...
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
